Abstract:OBJECTIVE:To evaluate the inhibitory effect of small interfering RNA (siRNA) on the expressions of hypoxia inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) in retinal neovascularization in the mouse.METHODS:HIF-1alpha siRNA recombinant plasmid was constructed. Liposome mediated the expressive plasmid of enhanced green fluorescent protein (EGFP) pEGFP-N1 complex was injected into the vitreous of C57BL/6J mice. The expression of GFP was observed in retinal flat-mounts one day after injection. Randomized controlled trial was performed. There were totally ninety (seven-day-old) C57BL/6J mice in which seventeen mice were chosen as normal group and seventy-three mice were divided into five groups randomly including control model group, vector group and gene therapy group (HIF-1alpha siRNA group, VEGF siRNA group and co-transfection group), in which retinal neovascularization was induced by hypoxia. Liposome with vector plasmid, HIF-1alpha siRNA and VEGF165 siRNA were injected into the vitreous in the vector group, HIF-1alpha siRNA group and VEGF siRNA group respectively one day before mice were moved out to room air from the cabin. Liposome with HIF-1alpha siRNA and VEGF165 siRNA was injected in the co-transfection group at the same time point. Fluorescent angiography was used to assess the vascular pattern. The proliferative neovascular response was quantified by counting the nuclei of new vessels extending from the retina into the vitreous in cross-sections. HIF-1alpha and VEGF levels in retinas were measured by reverse transcriptase-polymerase chain reaction and Western blot. Significant differences between groups were evaluated by one-way analysis of variance, followed by a least-significant difference analysis.RESULTS:The GFP expression in retinal cells was observed one day after injection of liposome mediated pEGFP-N1 complex. Neovascular tufts and fluorescein leakage were decreased in gene therapy group especially in co-transfection group compared to the control model group. The neovascular nuclei were decreased in gene therapy group [HIF-1alpha siRNA group (27.73 +/- 2.33), VEGF siRNA group (15.43 +/- 3.23), co-transfection group (8.70 +/- 2.88)] compared to the other three groups (F = 3016.537, P < 0.01). The expression of HIF-1alpha mRNA and protein in retinas were increased in control model group (1.08 +/- 0.06, 0.383 +/- 0.009) and vector group (1.09 +/- 0.05, 0.386 +/- 0.010) as compared with normal group (0.81 +/- 0.07, 0.035 +/- 0.003), while decreased 57.4% and 52.5% respectively in the HIF-1alpha siRNA group (0.46 +/- 0.06, 0.182 +/- 0.008) as compared with control model group (F = 139.804, 2686.001; P < 0.01). The expression of VEGF mRNA and protein in retinas were increased significantly in control model group (1.53 +/- 0.07, 0.340 +/- 0.004) and vector group (1.59 +/- 0.06, 0.337 +/- 0.009) as compared with normal group (0.27 +/- 0.08, 0.051 +/- 0.008), while decreased significantly in gene therapy group especially co-transfection group (decreased 85.6% and 80.9% respectively) as compared with control model group (F = 421.423, 2513.583; P < 0.01).CONCLUSIONS:HIF-1alpha siRNA and VEGF165 siRNA can inhibit retinal neovascularization in the mouse effectively. Co-transfection of these two siRNAs shows the greatest inhibitory effect.

Sirna Targeting Mammalian Target of Rapamycin (mtor) Attenuates Experimental Proliferative Vitreoretinopathy

The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.

Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.

Inhibition of Mtor Signaling by Rapamycin Protects Photoreceptors from Degeneration in Rd1 Mice

Effect Of Robo1 On Retinal Pigment Epithelial Cells And Experimental Proliferative Vitreoretinopathy

Small Interference RNA Targeting Vascular Endothelial Growth Factor Gene Effectively Attenuates Retinal Neovascularization in Mice Model.

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Effectively Inhibits Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelium

Inhibition of Mtor Signaling Protects Photoreceptor Cells Against Serum Deprivation by Reducing Oxidative Stress and Inducing G2/M Cell Cycle Arrest.

Antisense Oligonucleotide Targeting C-Fos Mrna Limits Retinal Pigment Epithelial Cell Proliferation; A Key Step in the Progression of Proliferative Vitreoretinopathy

Inhibition of Retinal Neovascularization by Sirna Targeting VEGF(165).

Construction of a Stable Mouse Fibroblast Line Targeting Mammalian Target of Rapamycin by Lentivirus Mediated Short Hairpin RNA

Tumor Necrosis Factor-Alpha (Tnf-Α)-mediated in Vitro Human Retinal Pigment Epithelial (RPE) Cell Migration Mainly Requires Akt/mTOR Complex 1 (mtorc1), but Not Mtor Complex 2 (mtorc2) Signaling

Inhibition of Retinal Neovascularization by Gene Transfer of Small Interfering RNA Targeting HIF-1alpha and VEGF.

Inhibition of Vascular Endothelial Growth Factor Gene Expression by T7-siRNAs in Cultured Human Retinal Pigment Epithelial Cells.

[Inhibitory Effect of Interfering RNA Targeting HIF-1alpha and VEGF on Retinal Neovascularization in the Mouse].

Rapamycin Mediates Mtor Signaling in Reactive Astrocytes and Reduces Retinal Ganglion Cell Loss

Small Interfering RNA Targeting PGC-1α Inhibits VEGF Expression and Tube Formation in Human Retinal Vascular Endothelial Cells

Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model

Suppression of Retinal Neovascularization by Small-Interference RNA Targeting Erythropoietin.

Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.

[Hif-1Α Sirna Reduces Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity].